Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × inecalcitol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 75 fludarabine phosphate 63 Peripheral Blood Stem Cell Transplantation 62 Cyclosporine 51 Busulfan 49 Imatinib Mesylate 47 Mycophenolic Acid 42 Radiotherapy 40 Antilymphocyte Serum 39 Filgrastim 38 Tacrolimus 34 Dasatinib 33 Methotrexate 32 Whole-Body Irradiation 30 Methylprednisolone 26 nilotinib 23 Melphalan 23 Cord Blood Stem Cell Transplantation 23 Cytarabine 21 Interferon-alpha 20 Etoposide 19 sargramostim 13 Flow Cytometry 13 Therapeutics 10 Sirolimus 10 Polymerase Chain Reaction 10 bosutinib 9 Cyclosporins 9 Thiotepa 8 Hydroxyurea 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02949570 2016-10-31

ICT10

Hybrigenics Corporation

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon ⚡